ATE294181T1 - (3,4-a:3,4-c)carbazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen - Google Patents
(3,4-a:3,4-c)carbazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungenInfo
- Publication number
- ATE294181T1 ATE294181T1 AT03292545T AT03292545T ATE294181T1 AT E294181 T1 ATE294181 T1 AT E294181T1 AT 03292545 T AT03292545 T AT 03292545T AT 03292545 T AT03292545 T AT 03292545T AT E294181 T1 ATE294181 T1 AT E294181T1
- Authority
- AT
- Austria
- Prior art keywords
- production
- pharmaceutical preparations
- preparations containing
- containing same
- carbazole derivatives
- Prior art date
Links
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical class C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0212847A FR2845996A1 (fr) | 2002-10-16 | 2002-10-16 | Nouveaux derives de[3,4-a:3,4-c]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE294181T1 true ATE294181T1 (de) | 2005-05-15 |
Family
ID=29725330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03292545T ATE294181T1 (de) | 2002-10-16 | 2003-10-14 | (3,4-a:3,4-c)carbazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US7151108B2 (de) |
| EP (1) | EP1411057B1 (de) |
| JP (1) | JP2004277404A (de) |
| KR (1) | KR100502250B1 (de) |
| CN (1) | CN1241925C (de) |
| AR (1) | AR041618A1 (de) |
| AT (1) | ATE294181T1 (de) |
| AU (1) | AU2003254746A1 (de) |
| BR (1) | BR0304575A (de) |
| CA (1) | CA2443585A1 (de) |
| DE (1) | DE60300571T2 (de) |
| DK (1) | DK1411057T3 (de) |
| EA (1) | EA007250B1 (de) |
| ES (1) | ES2240927T3 (de) |
| FR (1) | FR2845996A1 (de) |
| MA (1) | MA27007A1 (de) |
| MX (1) | MXPA03009362A (de) |
| MY (1) | MY134620A (de) |
| NO (1) | NO20034614L (de) |
| NZ (1) | NZ528902A (de) |
| PL (1) | PL362885A1 (de) |
| PT (1) | PT1411057E (de) |
| SG (1) | SG131765A1 (de) |
| SI (1) | SI1411057T1 (de) |
| ZA (1) | ZA200308053B (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI499414B (zh) | 2006-09-29 | 2015-09-11 | Lexicon Pharmaceuticals Inc | 鈉與葡萄糖第２型共同運輸體（ｃｏ-ｔｒａｎｓｐｏｒｔｅｒ ２）的抑制物與其應用方法 |
| US7846945B2 (en) | 2007-03-08 | 2010-12-07 | Lexicon Pharmaceuticals, Inc. | Piperdine-based inhibitors of sodium glucose co-transporter 2 and methods of their use |
| CA2939164A1 (en) | 2014-02-12 | 2015-08-20 | Iteos Therapeutics | Novel 3-(indol-3-yl)-pyridine derivatives, pharmaceutical compositions and methods for use |
| CN103804278B (zh) * | 2014-02-19 | 2016-04-13 | 西北大学 | 一种天然产物2-甲基-3-甲氧基-咔唑-1,4-苯醌的制备方法 |
| MD20160118A2 (ro) * | 2014-05-15 | 2017-04-30 | Iteos Therapeutics | Derivaţi ai pirolidin-2,5-dionei, compoziţii farmaceutice şi metode de utilizare ca inhibitori ai IDO1 |
| KR102013512B1 (ko) | 2015-03-17 | 2019-08-22 | 화이자 인코포레이티드 | 신규 3-인돌 치환 유도체, 제약 조성물 및 사용 방법 |
| JP2016216446A (ja) * | 2015-05-14 | 2016-12-22 | ファイザー・インク | ピロリジン−２，５−ジオン誘導体の多形形態、医薬組成物、およびｉｄｏ１阻害薬としての使用方法 |
| CA2994917A1 (en) | 2015-08-10 | 2017-02-16 | Pfizer Inc. | 3-indol substituted derivatives, pharmaceutical compositions and methods for use |
| CN106832175B (zh) * | 2017-02-17 | 2019-10-18 | 华南理工大学 | 一种基于咔唑衍生物的双羟基荧光扩链剂及其制备与应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3010675B2 (ja) * | 1989-03-23 | 2000-02-21 | 萬有製薬株式会社 | 抗腫瘍性物質ｂｅ―１３７９３ｃ |
-
2002
- 2002-10-16 FR FR0212847A patent/FR2845996A1/fr not_active Withdrawn
-
2003
- 2003-09-19 MY MYPI20033597A patent/MY134620A/en unknown
- 2003-09-26 US US10/672,418 patent/US7151108B2/en not_active Expired - Fee Related
- 2003-09-26 MA MA27327A patent/MA27007A1/fr unknown
- 2003-10-13 MX MXPA03009362A patent/MXPA03009362A/es active IP Right Grant
- 2003-10-14 ES ES03292545T patent/ES2240927T3/es not_active Expired - Lifetime
- 2003-10-14 PT PT03292545T patent/PT1411057E/pt unknown
- 2003-10-14 DK DK03292545T patent/DK1411057T3/da active
- 2003-10-14 DE DE60300571T patent/DE60300571T2/de not_active Expired - Fee Related
- 2003-10-14 SI SI200330032T patent/SI1411057T1/xx unknown
- 2003-10-14 EP EP03292545A patent/EP1411057B1/de not_active Expired - Lifetime
- 2003-10-14 AT AT03292545T patent/ATE294181T1/de not_active IP Right Cessation
- 2003-10-15 BR BR0304575-7A patent/BR0304575A/pt not_active IP Right Cessation
- 2003-10-15 CA CA002443585A patent/CA2443585A1/fr not_active Abandoned
- 2003-10-15 KR KR10-2003-0071768A patent/KR100502250B1/ko not_active Expired - Fee Related
- 2003-10-15 PL PL03362885A patent/PL362885A1/xx not_active Application Discontinuation
- 2003-10-15 EA EA200301020A patent/EA007250B1/ru unknown
- 2003-10-15 NO NO20034614A patent/NO20034614L/no not_active Application Discontinuation
- 2003-10-15 AR ARP030103744A patent/AR041618A1/es unknown
- 2003-10-15 NZ NZ528902A patent/NZ528902A/en unknown
- 2003-10-16 SG SG200306491-2A patent/SG131765A1/en unknown
- 2003-10-16 ZA ZA200308053A patent/ZA200308053B/xx unknown
- 2003-10-16 AU AU2003254746A patent/AU2003254746A1/en not_active Abandoned
- 2003-10-16 CN CNB200310100563XA patent/CN1241925C/zh not_active Expired - Fee Related
- 2003-10-16 JP JP2003355815A patent/JP2004277404A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA03009362A (es) | 2004-04-28 |
| DE60300571D1 (de) | 2005-06-02 |
| DE60300571T2 (de) | 2006-02-23 |
| JP2004277404A (ja) | 2004-10-07 |
| ZA200308053B (en) | 2004-07-08 |
| ES2240927T3 (es) | 2005-10-16 |
| EA007250B1 (ru) | 2006-08-25 |
| DK1411057T3 (da) | 2005-08-29 |
| EA200301020A1 (ru) | 2004-04-29 |
| FR2845996A1 (fr) | 2004-04-23 |
| CA2443585A1 (fr) | 2004-04-16 |
| AR041618A1 (es) | 2005-05-26 |
| US7151108B2 (en) | 2006-12-19 |
| PT1411057E (pt) | 2005-08-31 |
| KR100502250B1 (ko) | 2005-07-20 |
| SI1411057T1 (de) | 2005-08-31 |
| MY134620A (en) | 2007-12-31 |
| BR0304575A (pt) | 2004-07-20 |
| US20040077672A1 (en) | 2004-04-22 |
| NO20034614L (no) | 2004-04-19 |
| CN1241925C (zh) | 2006-02-15 |
| KR20040034472A (ko) | 2004-04-28 |
| AU2003254746A1 (en) | 2004-05-06 |
| PL362885A1 (en) | 2004-04-19 |
| CN1496989A (zh) | 2004-05-19 |
| NZ528902A (en) | 2004-09-24 |
| EP1411057A1 (de) | 2004-04-21 |
| NO20034614D0 (no) | 2003-10-15 |
| HK1063321A1 (en) | 2004-12-24 |
| SG131765A1 (en) | 2007-05-28 |
| EP1411057B1 (de) | 2005-04-27 |
| MA27007A1 (fr) | 2004-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE252562T1 (de) | Pyrazolcarbonsäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| DE69902535D1 (de) | Phenoxypropanolamin-derivate, verfahren zu ihrer herstellung und diese enthaltenden pharmazeutischen zusammensetzungen | |
| ATE279392T1 (de) | Indol-verbindungen, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und ihre medizinische anwendung | |
| ATE215951T1 (de) | Tetracyclische campothecineanalogue, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zubereitungen | |
| ATE252542T1 (de) | Benzolderivate, ein verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen,die diese enthalten | |
| DE60313602D1 (de) | N-iPHENYL(PIPERIDIN-2-YL)METHYLöBENZAMIDDERIVATE,VERFAHREN ZU IHRER HERSTELLUNG UND IHRE THERAPEUTISCHE ANWENDUNG | |
| DE60301570D1 (de) | 1,2,3-substituierte indolizinderivate, fgf inhibitoren, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
| ATE323092T1 (de) | Pyridopyrimidinon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| DE69909209D1 (de) | Pyrimidinon-derivate, diese verbindungen enthaltenden pharmazeutische zubereitungen und verfharen zu ihrer herstellung | |
| DE60318167D1 (de) | Arzneiform und Verfahren zu ihrer Herstellung | |
| ATE337317T1 (de) | Imidazopyrin-derivate, verfahren zu ihrer herstellung and sie enthaltende pharmazeutische zusamensetzungen | |
| ATE294175T1 (de) | 4-sulfonamid-piperidin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen | |
| ATE264837T1 (de) | N-guanidinalkylamide, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate | |
| ATE294181T1 (de) | (3,4-a:3,4-c)carbazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
| ATE222586T1 (de) | Benzolsulfonamidderivate und verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| DE60003662D1 (de) | Pyridothienodiazepine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
| ATE254124T1 (de) | Octahydro-2h-pyrido(1,2-a)pyrazinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
| ATE289595T1 (de) | Neue pyrimidin-2,4,6-trion-derivate, verfahren zu ihrer herstellung und pharmazeutische mittel die diese enthalten | |
| ATE248171T1 (de) | Isoindoloindolon-derivate, verfahren zu ihrer herstellung und die enthaltende pharmazeutische zusammensetzungen | |
| ATE292114T1 (de) | Arylalkanoylderivate, verfahren zu ihrer herstellung, ihre verwendung und diese enthaltende pharmazeutische zubereitungen | |
| DK1053224T3 (da) | Biphenylfulfonylcyanamider, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemiddel | |
| ATE374177T1 (de) | Cyclohexyl(alkyl)-propanolamine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| ATE344265T1 (de) | Derivate von benzothiazin und benzothiadiazin, verfahren zu ihrer herstellung und pharmazeutische zubereitungen diese enthaltend | |
| ATE250578T1 (de) | Indenoindolon-derivate, verfahren zu ihrer herstellung und die enthaltenden pharmazeutischen zusammensetzungen | |
| DE69804766D1 (de) | Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1411057 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |